Last update :
19/11/2024
Beta-stimulant   Arformoterol  
aerosol
Stability of pharmaceutical preparations Stability of mixtures Factors which affect stability Compatibility References pdf
   Chemical structure  

aerosol
Stability of mixtures   aerosol   Stability of mixtures : Arformoterol     
Container excipient Compound Temperature Storage Duration of stability References
Not specified
aerosol   Arformoterol Commercial Drug product15 µg/2 ml  Brovana®
aerosol   N-acetylcysteine Commercial Drug product800 mg/4 ml  Mucomyst®
25°C
0.5 Hour
Light 3019
Not specified
aerosol   Arformoterol Commercial Drug product15 µg/2 ml  Brovana®
aerosol   Budesonide Commercial Drug product0,25 mg/2 ml  Pulmicort®
25°C
0.5 Hour
Light 3019
Not specified
aerosol   Arformoterol Commercial Drug product15 µg/2 ml  Brovana®
aerosol   Budesonide Commercial Drug product0,5 mg/2 ml  Pulmicort®
25°C
0.5 Hour
Light 3019
Not specified
aerosol   Arformoterol Commercial Drug product15 µg/2 ml  Brovana®
aerosol   Ipratropium bromide Commercial Drug product0,5 mg/2,5 ml  Atrovent®
25°C
0.5 Hour
Light 3019

  Mentions Légales